A Tyrosine Kinase Inhibitor that Successfully Treats nAMD
We discuss the DAVIO trial of EYP-1901 with Dr. Jay S. Duker, Chief Operating Officer of Eyepoint Pharmaceuticals.
Explore " jay s. duker" with insightful episodes like and "A Tyrosine Kinase Inhibitor that Successfully Treats nAMD" from podcasts like " and "Retina Synthesis"" and more!
We discuss the DAVIO trial of EYP-1901 with Dr. Jay S. Duker, Chief Operating Officer of Eyepoint Pharmaceuticals.
Stay up to date
For any inquiries, please email us at hello@podcastworld.io